Cargando…
How selecting best therapy for metastatic NTRK fusion-positive non-small cell lung cancer?
The tropomyosin receptor kinase (TRK) family of receptor tyrosine kinases has become a focus of clinical interest because the NTRK genes (NTRK1-3) encoding them have been identified as oncogenic fusion genes in a wide range of different tumor types, including lung cancer. These NTRK gene fusions usu...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815373/ https://www.ncbi.nlm.nih.gov/pubmed/33489816 http://dx.doi.org/10.21037/tlcr-20-434 |